Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Paul J Bröckelmann; Boris Böll; Daniel Molin; Gundolf Schneider; Sirpa Leppä; Julia Meissner; Peter Kamper; Martin Hutchings; Jacob H Christensen; Ulf Schnetzke; Michael Fuchs; Janina Jablonski; Dennis A Eichenauer; Bastian von Tresckow; Wolfram Klapper; Carsten Kobe; Peter Borchmann; Alexander Fosså

doi:10.1002/hem3.70190

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Paul J Bröckelmann^*, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså

^*Corresponding author for this work

Department of Haematology

2 Citations (Scopus)

Original language	English
Article number	e70190
Journal	HemaSphere
Volume	9
Issue number	8
ISSN	2572-9241
DOIs	https://doi.org/10.1002/hem3.70190
Publication status	Published - Aug 2025

Access to Document

10.1002/hem3.70190Licence: CC BY-NC-ND

Cite this

Bröckelmann, P. J., Böll, B., Molin, D., Schneider, G., Leppä, S., Meissner, J., Kamper, P., Hutchings, M., Christensen, J. H., Schnetzke, U., Fuchs, M., Jablonski, J., Eichenauer, D. A., von Tresckow, B., Klapper, W., Kobe, C., Borchmann, P., & Fosså, A. (2025). Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients. HemaSphere, 9(8), Article e70190. https://doi.org/10.1002/hem3.70190

Bröckelmann, PJ, Böll, B, Molin, D, Schneider, G, Leppä, S, Meissner, J, Kamper, P, Hutchings, M, Christensen, JH, Schnetzke, U, Fuchs, M, Jablonski, J, Eichenauer, DA, von Tresckow, B, Klapper, W, Kobe, C, Borchmann, P & Fosså, A 2025, 'Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients', HemaSphere, vol. 9, no. 8, e70190. https://doi.org/10.1002/hem3.70190

@article{332abdb16abd4525a30637dc8001c71f,

title = "Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients",

author = "Br{\"o}ckelmann, \{Paul J\} and Boris B{\"o}ll and Daniel Molin and Gundolf Schneider and Sirpa Lepp{\"a} and Julia Meissner and Peter Kamper and Martin Hutchings and Christensen, \{Jacob H\} and Ulf Schnetzke and Michael Fuchs and Janina Jablonski and Eichenauer, \{Dennis A\} and \{von Tresckow\}, Bastian and Wolfram Klapper and Carsten Kobe and Peter Borchmann and Alexander Foss{\aa}",

year = "2025",

month = aug,

doi = "10.1002/hem3.70190",

language = "English",

volume = "9",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

AU - Bröckelmann, Paul J

AU - Böll, Boris

AU - Molin, Daniel

AU - Schneider, Gundolf

AU - Leppä, Sirpa

AU - Meissner, Julia

AU - Kamper, Peter

AU - Hutchings, Martin

AU - Christensen, Jacob H

AU - Schnetzke, Ulf

AU - Fuchs, Michael

AU - Jablonski, Janina

AU - Eichenauer, Dennis A

AU - von Tresckow, Bastian

AU - Klapper, Wolfram

AU - Kobe, Carsten

AU - Borchmann, Peter

AU - Fosså, Alexander

PY - 2025/8

Y1 - 2025/8

UR - https://www.scopus.com/pages/publications/105013507428

U2 - 10.1002/hem3.70190

DO - 10.1002/hem3.70190

M3 - Letter

C2 - 40832013

SN - 2572-9241

VL - 9

JO - HemaSphere

JF - HemaSphere

IS - 8

M1 - e70190

ER -

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Access to Document

Other files and links

Cite this